Molecular imaging and therapy of atherosclerosis with targeted nanoparticles

被引:161
|
作者
Wickline, Samuel A.
Neubauer, Anne M.
Winter, Patrick M.
Caruthers, Shelton D.
Lanza, Gregory M.
机构
[1] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[2] Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA
[3] Philips Med Syst, Best, Netherlands
关键词
nanotechnology; contrast agents; imaging; drug therapy; atherosclerosis;
D O I
10.1002/jmri.20866
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Advances in bionanotechnology are poised to impact the field of cardiovascular diagnosis and therapy for decades to come. This review seeks to illustrate selected examples of newly developed diagnostic and therapeutic nanosystems that have been evaluated in experimental atherosclerosis, thrombosis, and vascular biology. We review a variety of nanotechnologies that are capable of detecting early cardiovascular pathology, as well as associated imaging approaches and conjunctive strategies for site-targeted treatment with nanoparticle delivery systems.
引用
收藏
页码:667 / 680
页数:14
相关论文
共 50 条
  • [31] Radiopharmaceuticals:: From molecular imaging to targeted radionuclide therapy
    Schubiger, PA
    Grünberg, J
    Ametamey, SM
    Honer, M
    Garcia-Garayoa, E
    Bläuenstein, P
    Waibel, R
    Novak-Hofer, I
    Schibli, R
    CHIMIA, 2004, 58 (10) : 731 - 735
  • [32] Targeted molecular imaging in oncology: Focus on radiation therapy
    Nimmagadda, Sridhar
    Ford, Eric C.
    Wong, John W.
    Pomper, Martin G.
    SEMINARS IN RADIATION ONCOLOGY, 2008, 18 (02) : 136 - 148
  • [33] Biomedical Nanotechnology for Molecular Imaging, Diagnostics, and Targeted Therapy
    Nie, Shuming
    2009 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-20, 2009, : 4578 - 4579
  • [34] Molecular imaging as a tool for personalized and targeted anticancer therapy
    McLarty, K.
    Reilly, R. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (03) : 420 - 424
  • [35] Targeted ultrasonic contrast agents for molecular imaging and therapy
    Lanza, GM
    Wickline, SA
    PROGRESS IN CARDIOVASCULAR DISEASES, 2001, 44 (01) : 13 - 31
  • [36] Noninvasive Photodynamic Therapy of Murine Atherosclerosis Using Macrophage-Targeted Nanoparticles
    Kessinger, Chase W.
    El Mahgraby, Amr
    Erdem, S. S.
    Jetzfellner, Thomas
    Mauskapf, Adam
    Ntziachristos, Vasilis
    McCarthy, Jason R.
    Jaffer, Farouc A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34
  • [37] Targeted ultrasonic contrast agents for molecular imaging and therapy
    Lanza, GM
    Wickline, SA
    CURRENT PROBLEMS IN CARDIOLOGY, 2003, 28 (12) : 625 - 653
  • [38] Persistent antiangiogenic therapy with integrin-targeted fumagillin nanoparticles in early atherosclerosis
    Winter, PM
    Morawski, AM
    Caruthers, SD
    Harris, TD
    Hu, G
    Fuhrhop, RW
    Zhang, HY
    Allen, JS
    Lacy, EK
    Williams, TA
    Wickline, SA
    Lanza, GM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 435A - 435A
  • [39] Molecular Imaging of Angiogenic Therapy in Peripheral Vascular Disease With αvβ3-Integrin-Targeted Nanoparticles
    Winter, Patrick M.
    Caruthers, Shelton D.
    Allen, John S.
    Cai, Kejia
    Williams, Todd A.
    Lanza, Gregory M.
    Wickline, Samuel A.
    MAGNETIC RESONANCE IN MEDICINE, 2010, 64 (02) : 369 - 376
  • [40] CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma
    Wang, Lina
    Su, Weijun
    Liu, Ze
    Zhou, Manqian
    Chen, Si
    Chen, Yanan
    Lu, Dan
    Liu, Yanhua
    Fan, Yan
    Zheng, Yizhou
    Han, Zhongchao
    Kong, Deling
    Wu, Joseph C.
    Xiang, Rong
    Li, Zongjin
    BIOMATERIALS, 2012, 33 (20) : 5107 - 5114